CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Income Statement
USA - NASDAQ:CMMB - US16385C2035 - ADR
2.6505 USD
+0.02 (+0.78%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | 3.36M | 2.87M | N/A | |||
| Gross Profit | N/A | N/A | N/A | -2.87M | N/A | |||
| Operating Expenses | 12.67M | 14.74M | 22.10M | 25.66M | 12.37M | |||
| Research and Development | 9.03M | 11.23M | 18.24M | 13.87M | 6.33M | |||
| Selling, General, and Administrative Expenses | 3.65M | 3.51M | 7.21M | 11.80M | 6.03M | |||
| Operating Income | -12.67M | -14.74M | -25.46M | -28.53M | -12.37M | |||
| Interest Income/Expense | 846.00K | 794.00K | 1.24M | 350.00K | -110.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -11.83M | -13.95M | -24.22M | -28.18M | -12.48M | |||
| Income Tax | N/A | 0.00 | 0.00 | -530.00K | N/A | |||
| Net Income | -11.83M | -13.95M | -24.22M | -27.65M | -12.48M | |||
| EBITDA | N/A | -14.69M | -25.39M | -28.47M | -12.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.37 | -0.92 | -2.52 | -2.95 | -23.60 | |||
| Non GAAP EPS | N/A | -2.76 | N/A | -1.75 | -1.18 | |||
| Statistics | ||||||||
All data in USD